Drug and Therapeutics Bulletin 1997;35:7-8; doi:10.1136/dtb.1997.3517
Copyright © 1997 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Which prophylactic aspirin?

Relevant BNF sections: 2.9, 4.7.1

Low doses of aspirin are now a standard part of the management of patients with thromboembolic disease.1,2 One risk of taking even low doses is bleeding from the gut, and various aspirin formulations are marketed with claims that they reduce this problem. In this article we review the formulations available and consider their relative safety.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1997 BMJ Publishing Group Ltd.